text:
Demulen 1 / 35 Side Effects
Generic Name: ethinyl estradiol / ethynodiol
Note: This document contains side effect information about ethinyl estradiol / ethynodiol. Some of the dosage forms listed on this page may not apply to the brand name Demulen 1 / 35.
For the Consumer
Applies to ethinyl estradiol / ethynodiol: oral tablet
Along with its needed effects, ethinyl estradiol / ethynodiol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ethinyl estradiol / ethynodiol:
Incidence Not Known
- Absent, missed, or irregular menstrual periods
- anxiety
- bloody stools
- blurred vision
- breast tenderness, enlargement, discharge
- changes in skin color, pain, tenderness, or swelling of the foot or leg
- chest pain or discomfort
- chills
- clay-colored stools
- confusion
- cough
- dark or cloudy urine
- decrease in urine output or decrease in urine-concentrating ability
- diarrhea
- difficulty in speaking
- dizziness or lightheadedness
- double vision
- fainting
- fast heartbeat
- fever
- headache, severe and throbbing
- inability to move the arms, legs, or facial muscles
- inability to speak
- itching of the vagina or outside the genitals
- loss of appetite
- nausea
- nervousness
- pain during sexual intercourse
- pain or discomfort in the arms, jaw, back or neck
- pounding in the ears
- slow or fast heartbeat
- slow speech
- stomach pain and tenderness
- stopping of menstrual bleeding
- sweating
- swelling
- swelling, pain, or tenderness in the upper abdominal area
- tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area
- thick, white curd-like vaginal discharge without odor or with mild odor
- troubled breathing
- unpleasant breath odor
- unusual tiredness or weakness
- vomiting
- vomiting of blood
- yellow eyes or skin
Some side effects of ethinyl estradiol / ethynodiol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence Not Known
- Acne
- changes in appetite
- changes in weight
- decreased interest in sexual intercourse
- decreased milk production
- light vaginal bleeding between regular menstrual periods
- loss in sexual ability, desire, drive, or performance
- mental depression
- patchy brown or dark brown discoloration of the skin
For Healthcare Professionals
Applies to ethinyl estradiol / ethynodiol: oral tablet
Many of the adverse effects experienced by women on oral contraceptive combination products have been related to a relative excess or deficiency of the estrogen and progestin components of these formulations. The following categorizes many of the frequent adverse effects by relative excess or deficiency of these components.
Progestin Excess:
Acne, oily skin
Breast tenderness
Tiredness, fatigue
Increased appetite
Weight gain
Cholestatic jaundice
Progestin Deficiency:
Estrogen Excess:
Breast tenderness
Estrogen Deficiency:
Early/mid-cycle breakthrough bleeding
Increased spotting
A number of studies have suggested that use of oral contraceptives decreases the risk of ovarian cancer. Specifically, the risk of epithelial ovarian cancers is decreased by 40%. The protection against ovarian cancer may last for 10 to 15 years after discontinuation of oral contraceptives. After long term use (12 years), the risk of ovarian cancer is decreased by as much as 80%.
The risk of endometrial cancer is decreased by approximately 50%. Protection may last for 15 years after discontinuation and may be greatest for nulliparous women who may be at higher risk for endometrial carcinoma than other women.
The incidence of hospitalization for pelvic inflammatory disease is approximately 50% lower in women taking oral contraceptives. The reason for the decrease in the frequency (or severity) of pelvic inflammatory disease in women taking oral contraceptives has not been fully elucidated.
Some recent studies have suggested that the decrease in frequency of functional ovarian cysts reported with some older formulations may not occur in women taking newer low dose formulations.
One recent study (The Nurses' Health Study) has suggested that long term use of oral contraceptives is safe and does not adversely affect long term risk for mortality.[Ref]
General side effects may have included several non-contraceptive health benefits. These benefits may have included protection against two malignant neoplasms (endometrial carcinoma and ovarian cancer). In addition, use of oral contraceptive combinations decreases the frequency of benign breast tumors, ovarian cysts, ectopic pregnancy, menstrual irregularity, iron deficiency anemia, dysmenorrhea, and pelvic inflammatory disease.[Ref]
Gastrointestinal side effect have included nausea, which occurred in approximately 10% of treated women and was more frequent during the first cycles of therapy. Some early reports suggested an association between oral contraceptive use and gallbladder disease.[Ref]
Cases of oral contraceptive-induced esophageal ulceration and geographic tongue have been reported rarely.
More recent studies have suggested that the risk of gallbladder disease is minimal.[Ref]
A number of studies have examined a possible relationship between the use of oral contraceptives and the development of breast cancer. Many of the studies have reported conflicting results. A committee of the World Health Organization evaluated these studies and the risks of breast cancer and concluded that: "Numerous studies have found no overall association between oral contraceptive use and risk of breast cancer." In addition, the same committee also examined a possible relationship between oral contraceptive use and neoplasms of the uterine cervix and concluded that: "There are insufficient data to draw any firm conclusions regarding the effects of combined oral contraceptives on the risk of cervical adenocarcinoma."
The World Health Organization committee also noted that some studies "have found a weak association between long-term use of oral contraceptives and breast cancer diagnosed before the age of 36, and perhaps up to the age 45....It is unclear whether this observed association is attributable to bias, the development of new cases of cancer, or accelerated growth of existing cancers."
The World Health Organization committee further concluded that there is no increased risk of breast cancer in women over the age of 45 who have previously taken oral contraceptives. In addition, studies suggest that use of oral contraceptives does not place specific groups of women (like those with a family history of breast cancer) at higher or lower risk, and variations in the hormonal content of oral contraceptives do not influence the risk of breast cancer.
In general, studies evaluating the potential risk of cervical cancer in patients taking oral contraceptives have been complicated by the large number of confounding factors which make investigations into the epidemiology of this neoplasm difficult. Some studies have suggested that women taking oral contraceptives are at increased risk of dysplasia, epidermoid carcinoma, and adenocarcinoma of the cervix. However, other studies have not found such an association.[Ref]
Oncologic side effects have included reports of breast cancer.[Ref]
Detailed information concerning the effects of oral contraceptive therapy on lipid metabolism is available in the Endocrine paragraph of this side effect monograph.
Some early investigations of women taking high dose estrogen combinations (50 mcg or more of ethinyl estradiol or equivalent daily) suggested that such women may be at increased risk of cardiovascular complications (myocardial infarction, stroke, and vascular thrombosis, including venous thromboembolism). However, more recent large investigations of women taking low dose estrogen combinations have suggested that oral contraceptive use is not associated with an increased risk of serious cardiovascular complications in healthy non smoking women up to the age of 45. (For women aged 35 to 44 who smoke or who have preexisting systemic diseases that may affect the cardiovascular system, use of oral contraceptives is not recommended.)
However, some investigators have suggested that even the new low dose products may result in adverse effects on lipid metabolism and should prompt careful review of a woman's cardiovascular risk factors before a decision to use oral contraceptive combinations is made.
The frequency of both subarachnoid hemorrhage and thrombotic stroke has been reported by some investigators to be higher in women taking oral contraceptive hormones. However, other investigators have suggested that the risk of these effects for women using newer low dose formulations are very small for young women without underlying cardiovascular disease or other risk factors.[Ref]
Cardiovascular side effects of the estrogen component of this combination drug have included significant hypertension. However, significant blood pressure increases generally occurred only in women receiving high-dose estrogen products (50 mcg or more of ethinyl estradiol or equivalent daily). Estrogens have also been associated with edema. In addition, exogenous estrogens may have exerted cardio-protective effects by causing favorable changes in lipid profiles. These beneficial effects, however, may have been partially or completely offset by alterations in lipid profiles induced by exogenous progestins.[Ref]
Endocrine side effects have included complex alterations in plasma lipid profiles and carbohydrate metabolism. In addition, oral contraceptive use has been reported to cause conception delay.[Ref]
All the progestins which occur in commercially available oral contraceptive combinations have adverse effects on lipid profiles. Specifically, these progestins exert antiestrogen and androgen effects and decrease HDL (and HDL2) cholesterol levels and increase LDL cholesterol levels. However, the estrogens in oral contraceptive combinations exert opposing effects. Consequently, alterations in lipid profiles are related to the relative amount and potency of the specific estrogen and progestin in a given product. (Ethynodiol exerts moderate progestin and androgen effects and a weak antiestrogen effect.)
A number of investigations have suggested that oral contraceptive combinations may decrease glucose tolerance. However, some recent studies with low dose preparations have suggested that decreases in glucose tolerance due to oral contraceptive combinations are generally minimal.
Despite the potentially adverse effects of oral contraceptives on lipid levels and glucose tolerance, some investigators have suggested that young diabetic women without existing vascular disease or severe lipidemias may be candidates for low dose oral contraceptive combinations provided that they receive close monitoring for adverse metabolic effects.[Ref]
The rate of death due to hepatocellular carcinoma in the United States has not changed during the last 25 years (a time during which use of oral contraceptive hormones has increased dramatically).
A committee of the World Health Organization has reported that in developing countries where hepatitis B virus infection and hepatocellular carcinoma are common, "short term use of oral contraceptives does not appear to be associated with an increased risk. Data on the effects of long term use are scarce."
A recent Italian case-control study of women with hepatocellular carcinoma has suggested that the relative risk of hepatocellular carcinoma is 2.2 for oral contraceptive users compared to women who never used oral contraceptives.
A similar American case-control study from 1989 also reported a strong association between oral contraceptive use and hepatocellular carcinoma but concluded that: "If this observed association is causal, the actual number of cases of liver cancer in the United States attributable to oral contraceptive use is small. Therefore, these findings do not have public health importance in the United States and other Western nations."[Ref]
Hepatic side effects have included focal nodular hyperplasia, intrahepatic cholestasis, liver cell adenomas, hepatic granulomas, hepatic hemangiomas and well-differentiated hepatocellular carcinomas.[Ref]
Hematologic side effects have included thromboembolism. However, because the dose of exogenous estrogens is low in most commercially available preparations, the risk has been minimal for most women (except women who are over age 35 and smoke and women with a previous history of thrombotic diseases).[Ref]
Cases of venous thrombosis, pulmonary embolism (sometimes fatal), and arterial thrombosis have been reported rarely.
Previous thrombotic disease is considered a contraindication to use of oral contraceptive combinations.[Ref]
Some women experience oligomenorrhea and amenorrhea following termination or oral contraceptive use.[Ref]
Genitourinary side effects have included breakthrough bleeding and spotting, especially during the first several cycles of oral contraceptive use. Non-hormonal causes of such bleeding should be excluded.[Ref]
Psychiatric side effects have included depression and precipitation of panic disorder.[Ref]
Immunologic side effects have included systemic lupus erythematosus, which has been reported rarely.[Ref]
Other side effects have included a case of fatal pulmonary occlusive disease associated with oral contraceptive therapy.[Ref]
Nervous system
Nervous system side effects have included chorea, which has been reported once in association with oral contraceptives.[Ref]
Ocular side effects have included retinal thrombosis, which has been reported rarely. In addition, the manufacturers of oral contraceptive products have reported that some patients develop changes in contact lens tolerance.[Ref]
1. "Product Information. Ortho-Novum (oral contraceptive combination pill)." Ortho Pharmaceutical Corporation, Raritan, NJ.
2. Peterson HB, Lee NC "Long-term health risks and benefits of oral contraceptive use." Obstet Gynecol Clin North Am 17 (1990): 775-88
3. "Oral contraceptives and neoplasia. WHO Scientific Group." World Health Organ Tech Rep Ser 817 (1992): 1-46
4. Friedman AJ, Wheeler JM "Incidence of ovarian cyst formation in women taking ethynodiol diacetate, 1mg, with ethinyl estradiol, 35 micrograms." J Reprod Med 36 (1991): 345-9
5. John EM, Whittemore AS, Harris R, Itnyre J "Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group." J Natl Cancer Inst 85 (1993): 142-7
6. Burkman RT Jr "Benefits and risk of oral contraceptives. A reassessment." J Reprod Med 36 (1991): 217-8
7. Lanes SF, Birmann B, Walker AM, Singer S "Oral contraceptive type and functional ovarian cysts." Am J Obstet Gynecol 166 (1992): 956-61
8. Colditz GA "Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study." Ann Intern Med 120 (1994): 821-6
9. Steinberg WM "Oral contraception: risks and benefits." Adv Contracept 5 (1989): 219-28
10. Gross TP, Schlesselman JJ "The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer." Obstet Gynecol 83 (1994): 419-24
11. Grimes DA "The safety of oral contraceptives: epidemiologic insights from the first 30 years." Am J Obstet Gynecol 166 (1992): 1950-4
12. Holt VL, Daling JR, McKnight B, Moore D, Stergachis A, Weiss NS "Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives." Obstet Gynecol 79 (1992): 529-33
13. Hankinson SE, Colditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ "A quantitative assessment of oral contraceptive use and risk of ovarian cancer." Obstet Gynecol 80 (1992): 708-14
14. Oren R, Fich A "Oral contraceptive-induced esophageal ulcer. Two cases and literature review." Dig Dis Sci 36 (1991): 1489-90
15. Waltimo J "Geographic tongue during a year of oral contraceptive cycles." Br Dent J 171 (1991): 94-6
16. Shoupe D "Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone." Obstet Gynecol 83 (1994): 679-85
17. Calle EE, Heath CW, Miraclemcmahill HL, Coates RJ, Liff JM, Franceschi S, Talamini R, Chantarakul N, Koetsawang S, Rachawat D "Breast cancer and hormonal contraceptives: further results." Contraception 54 (suppl (1996): s1-106
18. Turnquest MA "Oral contraceptive use and incidence of cervical intraepithelial neoplasia." Am J Obstet Gynecol 168 (1993): 1895-6
19. Delgado-Rodriguez M, Sillero-Arenas M, Martin-Moreno JM, Galvez-Vargas R "Oral contraceptives and cancer of the cervix uteri. A meta-analysis." Acta Obstet Gynecol Scand 71 (1992): 368-76
20. Murray PP, Stadel BV, Schlesselman JJ "Oral contraceptive use in women with a family history of breast cancer." Obstet Gynecol 73 (1989): 977-83
21. Jones MW, Silverberg SG "Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives." Obstet Gynecol 73 (1989): 984-9
22. Thomas DB "Oral contraceptives and breast cancer: review of the epidemiologic literature." Contraception 43 (1991): 597-642
23. Kaunitz AM "Oral contraceptives and gynecologic cancer: an update for the 1990s." Am J Obstet Gynecol 167 (1992): 1171-6
24. Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S "Breast cancer before age 45 and oral contraceptive use: new findings." Am J Epidemiol 129 (1989): 269-80
25. Mishell DR "Contraception." N Engl J Med 320 (1989): 777-85
26. Schlesselman JJ "Oral contraceptives and breast cancer." Am J Obstet Gynecol 163 (1990): 1379-87
27. Olsson H, Moller TR, Ranstam J "Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden." J Natl Cancer Inst 81 (1989): 1000-4
28. Brinton LA "Oral contraceptives and cervical neoplasia." Contraception 43 (1991): 581-95
29. Ewertz M "Oral contraceptives and breast cancer risk in Denmark." Eur J Cancer 28A (1992): 1176-81
30. Zondervan KT, Carpenter LM, Painter R, Vessey MP "Oral contraceptives and cervical cancer - further findings from the oxford family planning association contraceptive study." Br J Cancer 73 (1996): 1291-7
31. Rettig BA, Lemon HM "Cancers related to contraceptive use." Br J Cancer 74 (1996): 1509-10
32. Lavecchia C, Negri E, Franceschi S, Talamini R, Amadori D, Filiberti R, Conti E, Montella M, Veronesi A, Parazzini F, Ferraroni M "Oral contraceptives and breast cancer: a cooperative italian study." Int J Cancer 60 (1995): 163-7
33. Romieu I, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE "Prospective study of oral contraceptive use and risk of breast cancer in women." J Natl Cancer Inst 81 (1989): 1313-21
34. Lund E "Oral contraceptives and breast cancer. A review with some comments on mathematical models." Acta Oncol 31 (1992): 183-6
35. Rosenberg L, Palmer JR, Clarke EA, Shapiro S "A case-control study of the risk of breast cancer in relation to oral contraceptive use." Am J Epidemiol 136 (1992): 1437-44
36. Sillero-Arenas M, Rodriguez-Contreras R, Delgado-Rodriguez M, Bueno-Cavanillas A, Galvez-Vargas R "Patterns of research. Oral contraceptives and cervical cancer." Acta Obstet Gynecol Scand 70 (1991): 143-8
37. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK "Stroke in users of low-dose oral contraceptives." N Engl J Med 335 (1996): 8-15
38. Derman RJ "Oral contraceptives and cardiovascular risk. Taking a safe course of action." Postgrad Med 88 (1990): 119-22
39. Poulter NR, Chang CL, Farley TMM, Meirik O, Marmot MG "Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study." Lancet 348 (1996): 505-10
40. Lidegaard O "Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study." BMJ 306 (1993): 956-63
41. Derman R "Oral contraceptives: a reassessment." Obstet Gynecol Surv 44 (1989): 662-8
42. Vandenbroucke JP, Bloemenkamp KWM, Helmerhorst FM, Rosendaal FR "Oral contraceptives and mortality from venous thromboembolism - reply." Lancet 348 (1996): 1096-7
43. Thorogood M "Risk of stroke in users of oral contraceptives." JAMA 281 (1999): 1255-6
44. Thorogood M, Mann J, Murphy M, Vessey M "Fatal stroke and use of oral contraceptives: findings from a case- control study." Am J Epidemiol 136 (1992): 35-45
45. Hannaford PC, Croft PR, Kay CR "Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study." Stroke 25 (1994): 935-42
46. Piegsa K, Guillebaud J "Oral contraceptives and the risk of DVT." Practitioner 240 (1996): 544
47. Farley TMM, Meirik O, Poulter NR, Chang CL, Marmot MG "Oral contraceptives and thrombotic diseases: impact of new epidemiological studies." Contraception 54 (1996): 193-5
48. Rosenberg L, Palmer JR, Lesko SM, Shapiro S "Oral contraceptive use and the risk of myocardial infarction." Am J Epidemiol 131 (1990): 1009-16
49. Leaf DA, Bland D, Schaad D, Neighbor WE, Scott CS "Oral contraceptive use and coronary risk factors in women." Am J Med Sci 301 (1991): 365-8
50. Speroff L "Oral contraceptives and venous thromboembolism." Int J Gynaecol Obstet 54 (1996): 45-50
51. Williams RS "Benefits and risks of oral contraceptive use." Postgrad Med 92 (1992): 155-7
52. Levine AB, Teppa J, Mcgough B, Cowchock FS "Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives." Contraception 53 (1996): 255-7
53. Martinelli I, Rosendaal FR, Vandenbroucke JP, Mannucci PM "Oral contraceptives are a risk factor for cerebral vein thrombosis." Thromb Haemost 76 (1996): 477-8
54. Norris LA, Bonnar J "The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives." Br J Obstet Gynaecol 103 (1996): 261-7
55. Farmer R, Lewis M "Oral contraceptives and mortality from venous thromboembolism." Lancet 348 (1996): 1095
56. Poulter NR, Chang CL, Farley TMM, Meirik O, Marmot MG, Debertribeiro M, Medina E, Artigas J, Shen H, Zhong YH, Zhang DW, "Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study." Lancet 348 (1996): 498-505
57. Thorneycroft IH "Oral contraceptives and myocardial infarction." Am J Obstet Gynecol 163 (1990): 1393-7
58. Spellacy WN, Ellingson AB, Tsibris JC "The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use." Fertil Steril 51 (1989): 71-4
59. Burkman RT, Zacur HA, Kimball AW, Kwiterovich P, Bell WR "Oral contraceptives and lipids and lipoproteins: Part I--Variations in mean levels by oral contraceptive type." Contraception 40 (1989): 553-61
60. Hannaford PC, Kay CR "Oral contraceptives and diabetes mellitus." BMJ 299 (1989): 1315-6
61. Miwa LJ, Edmunds AL, Shaefer MS, Raynor SC "Idiopathic thromboembolism associated with triphasic oral contraceptives." DICP 23 (1989): 773-5
62. Bracken MB, Hellenbrand KG, Holford TR "Conception delay after oral contraceptive use: the effect of estrogen dose." Fertil Steril 53 (1990): 21-7
63. Stubblefield PG "Choosing the best oral contraceptive." Clin Obstet Gynecol 32 (1989): 316-28
64. Kjaer K, Hagen C, Sando SH, Eshoj O "Contraception in women with IDDM. An epidemiological study." Diabetes Care 15 (1992): 1585-90
65. Godsland IF, Crook D "Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk." Am J Obstet Gynecol 170 (1994): 1528-36
66. Janaud A, Rouffy J, Upmalis D, Dain MP "A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel." Acta Obstet Gynecol Scand Suppl 156 (1992): 33-8
67. Garg SK, Chase HP, Marshall G, Hoops SL, Holmes DL, Jackson WE "Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus." JAMA 271 (1994): 1099-102
68. Mooney MJ, Nyreen MR, Hall RA, Carter PL "Hepatic adenoma presenting as a right lower quadrant mass." Am Surg 59 (1993): 229-31
69. Weden M, Glaumann H, Einarsson K "Protracted cholestasis probably induced by oral contraceptive." J Intern Med 231 (1992): 561-5
70. Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C "Female hormone utilisation and risk of hepatocellular carcinoma." Br J Cancer 67 (1993): 635-7
71. Palmer JR, Rosenberg L, Kaufman DW, Warshauer ME, Stolley P, Shapiro S "Oral contraceptive use and liver cancer." Am J Epidemiol 130 (1989): 878-82
72. Mathieu D, Zafrani ES, Anglade MC, Dhumeaux D "Association of focal nodular hyperplasia and hepatic hemangioma." Gastroenterology 97 (1989): 154-7
73. Tao LC "Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma." Cancer 68 (1991): 341-7
74. Aldinger K, Ben-Menachem Y, Whalen G "Focal nodular hyperplasia of the liver associated with high-dosage estrogens." Arch Intern Med 137 (1977): 357-9
75. Conter RL, Longmire WP Jr "Recurrent hepatic hemangiomas. Possible association with estrogen therapy." Ann Surg 207 (1988): 115-9
76. Le Bail B, Jouhanole H, Deugnier Y, Salame G, Pellegrin JL, Saric J, Balabaud C, Bioulac-Sage P "Liver adenomatosis with granulomas in two patients on long-term oral contraceptives." Am J Surg Pathol 16 (1992): 982-7
77. Gyorffy EJ, Bredfeldt JE, Black WC "Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use." Ann Intern Med 110 (1989): 489-90
78. Lidegaard O "Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease." Br J Obstet Gynaecol 102 (1995): 153-9
79. Beaumont V, Lemort N, Beaumont JL "Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases." Eur Heart J 12 (1991): 1219-24
80. Key JD, Hammill WW, Everett L "Pulmonary embolus in an adolescent on oral contraceptives." J Adolesc Health 13 (1992): 713-5
81. Ushiroyama T, Okamoto Y, Toyoda K, Sugimoto O "A case of panic disorder induced by oral contraceptive." Acta Obstet Gynecol Scand 71 (1992): 78-80
82. Deci PA, Lydiard RB, Santos AB, Arana GW "Oral contraceptives and panic disorder." J Clin Psychiatry 53 (1992): 163-5
83. Iskander MK, Khan M "Chorea as the initial presentation of oral contraceptive related systemic lupus erythematosus." J Rheumatol 16 (1989): 850-1
84. Julkunen H, Kaaja R, Jouhikainen T, Teppo AM, Friman C "Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives." Br J Rheumatol 30 (1991): 471-2
85. Townend JN, Roberts DH, Jones EL, Davies MK "Fatal pulmonary venoocclusive disease after use of oral contraceptives." Am Heart J 124 (1992): 1643-4
86. Omdal R, Roalso S "Chorea gravidarum and chorea associated with oral contraceptives-- diseases due to antiphospholipid antibodies?" Acta Neurol Scand 86 (1992): 219-20
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about Demulen 1/35 (ethinyl estradiol / ethynodiol)
Consumer resources
Other brands: Zovia 1/35E, Kelnor 1/35, Demulen 1/50, Zovia 1/50E


text:
Like Us on Facebook and you are automatically entered to win a free gourmet meal delivered to your home.
Gift Certificate Redemption Notice: IF YOU RECEIVED A HOLIDAY GIFT CERTIFICATE PLEASE EMAIL YOUR NAME, REDEMPTION CODE, AND CHOICE OF MENU TO firstname.lastname@example.com. WE WILL SHIP GIFT CERTIFICATE ORDERS EACH WEDNESDAY.
Simply place five (5) orders with GourmetStation and receive a gift certificate
for a free gourmet dinner for two. Shipping is also included so you pay nothing
for these free dinners. You may redeem the gift certificate as a treat for
yourself or a gift for another.
It's simple. You may register by clicking here. You'll also receive the benefits of streamlined checkout. After you register you must sign in each time you shop at GourmetStation. By signing in our system recognizes you and makes sure you receive credit for your purchase. If you do not sign in, you will not receive credit.
After placing five (5) orders with GourmetStation our system will recognize that you are entitled to a free gourmet dinner for two. An email gift certificate will automatically be sent to the email address under your account. A redemption code will be included with the email gift certificate and you may redeem online.
No, we will hold the certificate open until you are ready to redeem.
Yes, just designate their name and address in the shipping information when
you redeem.

subset: commoncrawl


text:
"I am excited to see a percussion group in Sturgis," said Jill Toner of Sturgis, who came to Saturday's Identity Cubed show at Sturges-Young Auditorium with her family.
"I am excited to see a percussion group in Sturgis," said Jill Toner of Sturgis, who came to Saturday's Identity Cubed show at Sturges-Young Auditorium with her family.
"I heard about the show on pubic radio," said Kathy Orsted, who traveled from Portage to see the group. "I heard that they play non-traditional instruments and I have never experienced a percussion group before so I am looking forward to it," she said.
The show opened with the Identity Cubed trio taking the stage, which was cluttered with numerous musical instruments, but dominated by a few large marimbas and a vibraphone.
The trio opened with a piece called Belford, which they performed in precision on opera gongs placed horizontally on a foam-lined table, before moving with machine-like maneuvers to performing a very melodic piece on three marimbas -"C sharp Bach."
The trio then moved on to "table music", which was exactly as described.
The three sat at a table that supported three pieces of wood tabletops and performed what they described as "Ballet for the Hands," where the trio kept in total sync with each other in both sound and movement.
In a question and answer session after the show, the trio revealed that they spent a good hour in Lowe's tapping on different wood to find the right wood for this number.
Watching their hands move in perfect synchronicity, while creating music with nothing more than the tapping of their hands, Identity Cubed rapped, tapped and clapped out a tune that while comprised totally from sounds made from hand hitting wood, created a unique cypress symphony.
After a brief intermission, which the group spent adding and removing musical instruments to the stage, the second half began with, "Out of Frame," a piece a composer sent to them, which they performed on the large marimbas.
This heavenly-sounding piece evoked a very peaceful, serene feeling.
With hints of tropical vibrations, the happy, peaceful, uplifting feeling their music exuded felt at times whimsical and dreamlike.
The trio treated the audience to their own composed piece, "Vintage Clock Patterns," which was broken into five movements — all inspired by timepieces.
The first movement was inspired by old timepieces that ran fast. The second was about a stopwatch, the third about a grandfather clock; the fourth about ticking and the fifth was about the quartz itself.
The tune, which was played out on piano, vibraphone, snare drum, cymbal, wind chime, and a cello bow string strummed against the tiles of a vibraphone, incredibly created all the sounds that clocks are known to make.
Moving back to the marimbas, the trio performed, "Sculptures in Wood," which sounded very reminiscent of songs one might hear in a supper club during the '70s – very relaxing and mellow in both melody and movement.
Closing with a wild and crazy tune the trio strategically snapped out on three snare drums surrounded by bongos and opera gongs, Identity Cubed ended the night on a high, sharp note that displayed the group's past drum line discipline, performing with such exact precision that it felt like you were watching a performance at a drum corp competition.
"They were incredible!" said Hank Schultz of Sturgis. "I was very impressed how they made music from all kinds of things and never missed a beat and always remained in perfect sync with one another. It was a truly polished performance and I am glad I got to see it here – right at home - in Sturgis!"


text:
Moderators: Three Stars, dagny, pfim, netwolf
According to Max Marchi's work on The Hardball Times presented earlier this year, Barajas is one of the game's very best pitch framers. Among starting catchers, only Russell Martin and Brian McCann do better in that area, which was pretty much impossible to evaluate before PITCHf/x data came along.
MWB wrote:Give me a break about perspective. just because I'm a Yankees fan doesn't mean I don't know how screwed up the financials are. I also know that when small market owners had chances to do something about it they held out their hands, accepted money, and accepted losing.
How would you fix the problem? Big market teams are playing within the financial rules that all the owners accepted. What makes the small and mid market teams say, I care more about level financial playing fields than I do about lining my pocket?
The umpire issue you're talking about is, at most, minuscule, even based on the stats and sites you linked.
The offense was quite good, even with home plate umpire Brian O'Nora's terrible strike zone that messed with more than one at-bat (off the top of my head, both Pedro Alvarez and Andrew McCutchen took early-count strikes that were several inches off of the plate, which necessitated bad two-strike swings at pitches well out of the strike zone with runners on base at points in the game where a comeback seemed somewhat feasible).
Rocco wrote:Once an umpire expands the strike zone, it puts the hitter between a rock and a hard place of choosing whether to take a pitch that should be a strike but isn't or chase a pitch he can't hit but has to swing at since he's behind in the count and can't afford to strike out. The fact that it's done under the canard of pitch-framing makes it even more galling.
Troy Loney wrote:I'm curious if the offseason winner (Dodgers, Angels, Blue Jays) will continue to be terrible while the offseason losers (Yankees and Rangers) continue looking strong.
Rocco wrote:Uh oh.
http://www.cbssports.com/mlb/blog/eye-o ... es-andrews
KennyTheKangaroo wrote:Rocco wrote:Uh oh.
http://www.cbssports.com/mlb/blog/eye-o ... es-andrews
wasnt dylan bundy the guy that had the REVOLUTIONARY LONG TOSS PROGRAM that would prevent a sore arm let alone a trip to the one and only dr james andrews
Rocco wrote:Carlos Marmol has the most wins of any Cub pitcher. He must be an awesome reliever!
columbia wrote:Rocco wrote:Carlos Marmol has the most wins of any Cub pitcher. He must be an awesome reliever!
Who exactly are you trying to troll with these comments?
MWB wrote::shock:
Rocco and I actually agree on something.
Users browsing this forum: No registered users and 8 guests


text:
|Attention: DocWiki has reached EOL and will be decommissioned January 25, 2019.
Cisco IOS Voice Troubleshooting and Monitoring Guide
From DocWiki
|Welcome to Cisco DocWiki. We encourage registered Cisco.com users to contribute to this wiki to improve Cisco product documentation. Note that you cannot log in to DocWiki with Cisco.com "guest" account credentials.
See Terms of Use and About DocWiki for more information about Cisco DocWiki.
Click here to return to the Cisco IOS documentation on www.cisco.com.
==Print multiple DocWiki pages at once as a PDF document. See the DocWiki Print Page.==
This article provides guidance for troubleshooting issues that may appear when using Cisco IOS software for voice applications. Tools and methodologies are described that help to recognize a problem, determine its cause, and find possible solutions.
Troubleshooting Cisco IOS Voice Overview
To troubleshoot problems with voice networks, you must follow the call both inside the router and outside on the network in order to isolate the problem. You must understand the relationship of dial peers and call legs to follow the calls. For detailed information on dial peers and call legs, refer to Dial Peer Configuration on Voice Gateway Routers.
The following articles contain information about call flow:
Debug Command Output on Cisco IOS Voice Gateways
The debugging capability for Cisco voice gateways enables you to identify and track a specific call in a multiple-call environment. This capability allows you to correlate call information between gateways or to identify specific debug messages associated with a single call when multiple voice calls were simultaneously active.
Voice debug output contains a standardized header to the debug outputs of multiple voice modules, such as voice telephony service provider (VTSP), call control application program interface (CCAPI), session application (SSAPP), and interactive voice response (IVR).
The following information can be found in the Cisco IOS Debug Command Reference:
- Using debug commands is contained in the "Using Debug Commands" chapter.
- Conditionally triggered debugging is contained in the "Conditionally-Triggered Debugging" chapter.
- Details about individual debug commands are listed.
The following articles contain information about voice debug:
- Voice Debug Concepts
- Voice Call Debug Output Management
- Enhanced Debug Command Sample Output Examples
Filtering Troubleshooting Output
The methods for filtering troubleshooting output are in the following articles:
- Show and More Command Output Filtering.
- Voice Call Debug Filtering on Cisco Voice Gateways
- Voice Call Debug Filtering on H.323 Gatekeepers
- SIP Debug Output Filtering Support
- MGCP Call Centric Debug
Cisco VoIP Internal Error Codes
The Cisco VoIP Internal Error Codes feature generates internal error codes (IECs) for gateway-detected errors that cause the gateway to release or refuse a call. The following articles are about IECs:
Troubleshooting Cisco IOS Voice Telephony
If you are troubleshooting a connection to a PBX, you might find the PBX interoperability notes useful. These notes contain configuration information for Cisco gateways and several types of PBXs. To access these notes, use the following website: http://www.cisco.com/en/US/netsol/ns728/networking_solutions_program_category_home.html
Analog Voice Interface Troubleshooting
If you are troubleshooting an analog connection, you must understand what type of circuit and interface your voice port is using. Analog voice port interfaces connect routers in packet-based networks to analog two-wire or four-wire analog circuits in telephony networks. Two-wire circuits connect to analog telephone or fax devices, and four-wire circuits connect to PBXs.
Analog voice telephony interfaces include foreign exchange office (FXO), foreign exchange station (FXS), and receive and transmit (E&M). Direct Inward Dialing (DID) is a service offered by telephone companies that enables callers to dial directly to an extension on a PBX without the assistance of an operator or automated call attendant.
To troubleshoot analog voice interfaces, see the following articles:
- FXS Interfaces
- FXO Interfaces
- E&M Interfaces
- Analog DID Interfaces
- Analog Voice Port Testing Commands
Digital Voice Interface Troubleshooting
Digital voice ports are found at the intersection of a packet voice network and a digital, circuit-switched telephone network. Digital voice telephony interfaces include T1 or E1 channel-associated signaling (CAS), ISDN primary-rate interface (PRI) or basic rate interface (BRI), and E1 R2 signaling.
To troubleshoot digital voice interfaces, see the following articles:
- Digital Voice Interface Hardware Troubleshooting
- Digital Signal Processor Troubleshooting
- Codec Complexity Verification
- T1 or E1 Interface Troubleshooting
- Digital Voice-Port Configuration Verification
- Voice Port Testing Commands
VoIP Quality of Service Troubleshooting
The primary goal of Quality of Service (QoS) is to make network service better and more predictable by providing dedicated bandwidth, controlled jitter and latency, and improved loss characteristics. QoS achieves these goals by providing tools for managing network congestion, shaping network traffic, using expensive wide-area links more efficiently, and setting traffic policies across the network.
For information about configuring QoS for voice, refer to the Quality of Service for Voice document. For more information about QoS, refer to the Cisco IOS Quality of Service Solutions Configuration Guide.
For QoS troubleshooting, see the following articles:
Troubleshooting Cisco IOS Voice Protocols
H.323 Interface Troubleshooting
These articles provide troubleshooting information for the H.323 standard from the International Telecommunication Union Telecommunication Standardization Sector (ITU-T), of the following:
- Cisco H.323-compliant gatekeeper
- Cisco H.323-compliant gateway
- Cisco H.323-compliant features
Cisco IOS software complies with the mandatory requirements and several of the optional features of the H.323 Version 2 specification. The following articles describe H.323 features:
- H.323-Related Standards
- H.323 Gateway Troubleshooting
- H.323 Gatekeeper Troubleshooting
- H.323 Gateway-to-Gateway and Gatekeeper-to-Gateway Security
H.323 is a peer-to-peer protocol. H.323 uses messages similar to Q.931 messages to communicate between endpoints. Q.931 cause codes can be found in SIP and H.323 Internal Cause Codes.
SIP Interface Troubleshooting
The Cisco Session Initiation Protocol (SIP) implementation enables Cisco access platforms to signal the setup of voice and multimedia calls over IP networks. SIP is an ASCII-based, application-layer control protocol that can be used to establish, maintain, and terminate calls between two or more endpoints. SIP is an alternative protocol developed by the Internet Engineering Task Force (IETF) for multimedia conferencing over IP. SIP features are compliant with IETF RFC 2543, SIP: Session Initiation Protocol, published in March 1999. You can view RFC 2543 at http://www.ietf.org/rfc/rfc2543.txt.
Like other Voice-over-IP protocols, SIP is designed to address the functions of signaling and session management within a packet telephony network. Signaling allows call information to be carried across network boundaries. Session management provides the ability to control the attributes of an end-to-end call.
The following articles provide procedural and reference information that you can use to determine and resolve problems with SIP interfaces to the IP network.
|Call flows can help in troubleshooting SIP problems. SIP call flow information can be found in the Cisco IOS SIP Configuration Guide.
SIP troubleshooting can be found in the following articles:
- Cisco SIP IP Phone 7960 Troubleshooting
- Cisco SIP Gateway Troubleshooting
- Cisco SIP Proxy Server Troubleshooting
- SIP Messages and Methods
MGCP and Related Protocol Interface Troubleshooting
Media gateway control protocol (MGCP) bases its call control and intelligence in centralized call agents, also called media gateway controllers. The call agents issue commands to simple, low-cost endpoints, which are housed in media gateways (MGs), and they also receive event reports from the gateways. MGCP messages between call agents and media gateways are sent over IP/UDP.
For information about configuring MGCP, refer to the MGCP and Related Protocols Configuration Guide.
Use the following articles to troubleshoot MGCP:
- MGCP Overview
- MGCP Call Routing and Dial Peers
- MGCP Call Admission Control
- MGCP Connections and Endpoints Verification
- MGCP Testing Commands
Voice over Frame Relay Interface Troubleshooting
Voice over Frame Relay (VoFR) enables a router to carry voice traffic (for example, telephone calls and faxes) over a Frame Relay network, using the FRF.11 protocol. This protocol specification defines multiplexed data, voice, fax, dual-tone multifrequency (DTMF) digit-relay, and channel-associated signaling (CAS).
The Cisco VoFR implementation enables you to make dynamic- and tandem-switched calls and Cisco trunk calls. Dynamic-switched calls have dial-plan information included that processes and routes calls based on the telephone numbers. The dial-plan information is contained within dial-peer entries.
VoFR articles include the following topics:
- Frame Relay Troubleshooting Tasks
- VoFR with QoS Troubleshooting
- VoIP over Frame Relay with Multipoint PVCs and Prioritization Troubleshooting
- VoFR Testing Commands
Voice over ATM Interface Troubleshooting
Voice over ATM (VoATM) enables a router to carry voice traffic (for example, telephone calls and faxes) over an ATM network. To troubleshoot VoATM issues, see the following article:
Troubleshooting Cisco IOS Telephony Applications
Voice Application Troubleshooting
Tcl and VoiceXML applications on the Cisco gateway provide Interactive Voice Response (IVR) features and call control capabilities such as call forwarding and voice mail.
The Cisco voice gateway allows voice applications to be used during call processing. Typically, application scripts contain both executable files and audio files that interact with the system software. Tcl scripts and VoiceXML documents can be stored in any of the following locations: TFTP, FTP, or HTTP servers, Flash memory of the gateway, or on the removable disks of the Cisco 3600 series. The audio files that they reference can be stored in any of these locations, and on Real Time Streaming Protocol (RTSP) servers. A Cisco voice gateway can have several voice applications to accommodate many different services, and you can customize the voice applications to present different interfaces to the various callers. IP phones can also originate calls to a gateway running a voice application.
Voice applications on Cisco gateways can be developed using a choice of two scripting languages:
- Tcl IVR 2.0-Tcl-based scripting with an API.
- VoiceXML-Standards-based markup language for voice browsers.
Applications can also be developed using a hybrid of both Tcl and VoiceXML. The following articles describe troubleshooting Cisco IOS Tcl and VoiceXML applications:
- Tcl IVR Troubleshooting
- Media Inactive Call Detection
- Cisco VoiceXML Troubleshooting
- Tcl IVR Events and Status Codes
AAA and Billing Application Troubleshooting
To troubleshoot authentication, authorization, and accounting (AAA), billing, and settlement issues for voice services, refer to the following articles:
- AAA for Voice Troubleshooting
- Accounting Server Connectivity Failure and Recovery Detection
- Enhanced Billing Support for SIP Gateways Troubleshooting
- Settlement Troubleshooting
Fax Application Troubleshooting
This chapter describes T.37 store and forward fax and T.38 fax gateway troubleshooting concepts. The applications are T.37 store and forward fax, T.38 fax relay for VoIP H.323, fax relay packet loss concealment, and T.37/T.38 fax gateways. The applications enable the Cisco gateways to send and receive faxes across packet-based networks, using modems or voice feature cards (VFCs).
Before beginning these troubleshooting procedures, check to ensure your fax machine and voice network are working. Try the following steps to help isolate the problem:
- Plug the fax machine into a regular analog line and test the fax call while bypassing the voice network. If the problem persists, it could be the fax machine.
- If the fax machine has a handset, connect the fax machine to the voice network, pick the handset up, and try to make a voice call. If the voice call works, you have verified that your voice network is operational. A voice call must be successful before a fax call can succeed.
Fax troubleshooting includes the following articles:
For information about configuring fax features, refer to the Cisco IOS Fax, Modem, and Text Support over IP Configuration Guide.
Monitoring the Cisco IOS Voice Network
To monitor your voice network, use the following articles:
- Voice Network Monitoring
- Voice Performance Statistics on Cisco Gateways
- Configuring Voice Performance Statistics on Cisco Gateways
- Managing the Collection of Voice Statistics
- Voice Performance Statistics on Cisco Gateways Configuration Examples
Cause Codes and Debug Values
The following articles contain tables of cause codes and debug values:


text:
Hi Reductor and other friends,Reductor wrote:Hey all,
I downloaded that insight timer app, then searched for dhammawheel; KB has already made a group, so join up.
Would it be possible to provide the link for the group? Where to downlod the insight timer app?
Thanks and metta!
PS: please excuse me if these questions have already been answered. I didn't read the 7 pages of the thread.


text:
7:00 pm
The Lawrence Welk Show "Down on the Farm" This 1973 show features Norma Zimmer singing "Suddenly There's a Valley." Bobby and Cissy bring "Turkey in the Straw" to life. Joe Feeney soars on "Oh What a Beautiful Morning." Jimmy Roberts says to "Shine On Harvest Moon."G
8:00 pm
Are You Being Served? "Strong Stuff This Insurance" Grace Brothers' new group insurance scheme requires the staff to become fit before medical examinations.G
8:30 pm
Keeping Up Appearances - The Memoirs of Hyacinth Bucket "A Celebrity for the Barbecue" Hyacinth volunteers Richard's services at the Church Hall where there is a problem with the lights. However, he is less than successful in his chore.G
9:00 pm
As Time Goes By "Branching Out" Jean is opening another secretarial agency and looking for someone to run it. Meanwhile, work for Lionel seems to have dried up.G
9:30 pm
Outnumbered Mum finds an inappropriate image on the family computer. Karen, convinced she has won a large amount of money, starts to spend it. Ben brings his special talents to the ancient game of chess.G
10:00 pm
The Red Green Show "The Beaver Dam" Possum Lake is rising thanks to industrious beavers and their dam. Red uses empty duct tape rolls to make a beer cellar.G
10:30 pm
My Family "Let's Not Be Heisty" Ben's attempt to pay money into his bank account is thwarted when someone else tries to take some out - with the aid of sawed-off shotguns. Ben and Susan, along with others, are held as hostages. Ben decides to act as a negotiator.G
11:00 pm
Doctor Who Series "The Almost People" As the solar storm rages and the factory crumbles, a doppelganger driven mad by the memories of being "decommissioned" is seeking revenge. The Doctor must convince the terrified factory workers to embrace their own humanity and work together with the doppelgangers to overcome a monster of their own making.G
11:46 pm
Doctor Who: Confidential "Take Two" NULL


text:
Below is our collection of tidbits, odds 'n ends for Sambo.
While the name Sambo is unique within Alabama, we know of one more community in the United States.
Communities Outside of Alabama
Saint Landry Parish
Our profile page for Sambo, Saint Landry Parish [Map]
Search for a Community located in Alabama
About Talladega County
About Alabama
The official website for State of Alabama: https://www.alabama.gov/
Please keep in mind that we can not guarantee the accuracy or timeliness of the information
on this website, so use with care. We encourage you to double-check the information that is critical to you.
If you've found an error or have additional information that you would like to share,
please don't hesitate to write. Click here to contact us.


text:
There's nothing more sincere than boosting the human spirit, especially when it's of someone who is in need. In this case it's a former classmate of mine – Matt Littlefield.
I just learned late last week that Matt, 40, was diagnosed with AML (Acute Myeloid Leukemia). His condition was realized after initial blood tests revealed he was anemic. Per consultation with his oncologist, Matt and his wife, Andrea, made the trip to U of M hospital in Ann Arbor where he underwent a slew of tests and a chemotherapy regiment.
Thankfully Matt is in remission right now, but it's imperative he have a bone marrow transplant.
Matt and Andrea Littlefield have four children. Twins Ben and Brady and twins Andrew and Allison.
There are a number of ways to help Matt and his family during this difficult time.
You can visit Be The Match Foundation, where you can join Matt's team to find a bone marrow match. Be The Match is a nationwide community committed to helping patients in need of marrow transplant by raising funds to add more potential marrow donors to the registry. The link is below.
Donations to Matt's team will not only help Matt, but others looking for unrelated marrow or umbilical cord blood transplant.
Be The Match's efforts also help to recruit potential donors, support patients, educate doctors and medical professionals, as well as advance science.
You can also help The Littlefield's and Be The Match Foundation.Org by going to Sturgis Middle School on April 27, from 9 am to 1 pm. The event is being organized to help raise funds to purchase $25 test kits at no cost to participants.
Together, we can help find a marrow transplant.
Finding a match for Matt Littlefield
There's nothing more sincere than boosting the human spirit, especially when it's of someone who is in need. In this case it's a former classmate of mine – Matt Littlefield.


text:
50% off on first order
Let use/us/os do it.
Score 0/0 (0%)
Free quizzes every day
Justlearn creates hundreds of quizzes every month. Every quiz is made for you to learn English in the modern way. Every person can test their English level using our material for free. The Justlearn community welcomes any new member.
Hundreds of tutors and teachers are ready to provide private tutoring. The lessons is customized to your level and learning style. The teacher assists you using video chat. Try out the Justlearn classroom and experience personal learning.View English Tutors and Teachers


text:
Brand New Organza Overlays
Decorate the table cloths with these beautiful crystal organza overlays.
Also can be used to make huge bows or large area decoration. Available in 22 colors.
How to Care: Hand wash only. Hang dry, don't use dryer. Material: Nylon Approximate Measurements: 60"x60" Square Edges are Serged.
Click the "view more images" link above to review our color chart for overlays.
Item only consists of the overlay itself, does not include decorations, pins, tables.
We are confirming your subscription now...


text:
A multiple pregnancy is when a woman is pregnant with 2 or more fetuses. Twins are the most common type of multiple pregnancy. So-called "higher-order" pregnancies (when a woman is carrying triplets, quadruplets, quintuplets, or more) are less common.
The risk for certain complications during and after pregnancy is higher in multiple pregnancies. To lessen these risks, your doctor will see you more often than a woman carrying 1 baby.
Multiple pregnancies occur when a single fertilized egg divides and develops into 2 or more fetuses (identical twins) or when more than 1 egg is fertilized by a different sperm (fraternal twins). Triplets, quadruplets, and quintuplets can be identical, fraternal, or a combination of both.
Risk Factors
Multiple pregnancy is more common in women of African ancestry. It is also more common in women over 30.
Factors that may increase your changes of having a multiple pregnancy include:
- Use of fertility treatments
- A previous multiple pregnancy
- A family history of multiple births
- More than 1 previous pregnancy
Symptoms include the following:
- More rapid weight gain than expected in the first trimester
- Larger than expected uterus
- Severe morning sickness
- More fetal movement than with a singleton pregnancy
You will be asked about your symptoms and medical history. A physical exam will be done. Your doctor may refer you to a healthcare professional who has experience with multiple pregnancies.
Most multiple pregnancies are discovered during an ultrasound examination. An ultrasound examination is a test that uses sound waves to see how the fetus is developing.
Other tests that may detect a multiple pregnancy include:
- A higher result on certain blood tests done near the 16th week of pregnancy
- Hearing more than 1 heart beat during a routine examination
Multiple pregnancies have a greater risk for certain complications. If you experience any of these conditions, your doctor will discuss the best treatment plan for you.
Preterm Labor
Most multiple births are preterm (before the end of 37 weeks of pregnancy). Babies born preterm have a higher risk for many health problems. To delay preterm birth, your doctor may suggest bed rest at home or in a hospital or prescribe certain medications. If labor threatens to occur before 34 weeks of pregnancy, you may be given steroid medication to help your babies' lungs mature.
Gestational Diabetes
Gestational diabetes is a disorder in which the body becomes less sensitive to insulin resulting in high blood sugar levels. Gestational diabetes treatment aims to return blood sugar levels to normal through diet, exercise, blood sugar level testing, and sometimes insulin shots.
Preeclampsia is a condition occurring during pregnancy when a woman has high blood pressure and more than normal amounts of protein in her urine. Treatment may include drugs, rest, and early delivery of the babies.
Abnormal Fetal Position (Breech or Transverse)
More than 1 fetus in the uterus increases the chance that 1 of them will be unable to turn head down. A breech or transverse presentation increases the chance of needing a cesarean delivery.
Twin Twin Transfusion Syndrome (TTTS)
Twins sometimes share vessels in the placenta. If this sharing is unequal, this syndrome can develop. In TTTS, 1 twin transfuses (donates blood) to the other. The donor twin becomes anemic and the receiving twin develops problems of having too much blood and fluid in the body.
Postpartum Hemorrhage
More than 1 fetus in the uterus increases the chance of postpartum hemorrhage. This is heavy blood loss in the mother after delivering the babies.
To help reduce your chance of having health problems during a multiple pregnancy, take the following steps:
- Get early and regular prenatal care so your doctor can closely monitor your pregnancy.
- Follow general pregnancy nutrition advice, including getting more calcium, folic acid, protein, and iron in your diet.
- Gain the appropriate amount of weight, especially in the first 20-24 weeks of pregnancy.
Revision Information
- Reviewer: Andrea Chisholm, MD
- Review Date: 12/2016 -
- Update Date: 05/20/2015 -


text:
1) What a double-bounce walk is and how to draw one.
2) What a 10x beat feels like
A 12x beat is an easy natural feel.
An 8x beat has a quick uptempo feel.
A 10x beat is inbetween those 2. It feels urgent, like a march beat. Brisk and energetic.
The scene below is timed to a 10x beat.
All the main actions fall on multiples or divisions of 10s.
Watch it and feel it.
The Happy Happy Joy Joy Song is a 10x beat.
HERE'S JUST THE AUDIO (1.2mb)
Tap along to the beat. Each of your taps will be 10x apart.
The old cartoon directors used metronomes to time their scenes to. They would set the tempo they liked and act out the scene to the clicks. I use click tracks in my animatics.
HERE'S A 10 FRAME CLICK TRACK (1.5mb)
In a normal walk a character goes up and down once each time he takes a step. Usually when you step, your leg bends DOWN to take the weight then it pushes UP on the way to the next step. There are endless variations of this, but that's the concept.
In a double bounce walk, you go up and down twice in each step.
Not only do you go down as your foot contacts the ground, you go down again in the middle of the step.
WHY??? A double bounce step is musical. It's like a dance. It's fun. It's in lots of 30s cartoons. Porky Pig in Clampet's cartoons always walks double bounce. It shows that he's youthful and full of pep. It also conveys innocence.
DOUBLE BOUNCE WALK CYCLE + JOHN'S NOTES (4.5mb)
HERE'S A CLOSE-UP OF THE WALK, SLOW-MOTION, WITH JOHN'S NOTES (4.7mb)
Here's a 10x ex sheet in case you ever want to do some animation of your own to a 10x beat.
Here you can see exactly what I do in Flash to analyze a scene.
The Keys
STEP 2 left foot on ground (body leaning forward)
The other drawings in the cycle are basically inbetweens.
*** - but watch the foot that is off the ground...that won't pure pure inbetweens.
Ub Iwerks cartoons are great to study animation principles from. And they are really fun too.
If you wanna see where this lesson would fit into my ideal cartoon school curriculum click this rascal:
Later this week: Wanna watch me construct Bugs Bunny and Willoughby, step by step? Kali has made a film.


text:
TierraCast Dulce Vida Jardin Large Teardrop Charms - Romance Floral Swirl Flower Leaves Zen Doodle Antique Pewter Silver LEAD FREE 2497
Description: Dulce Vida is TierraCast's new line for 2017. Each piece has a beautiful floral pattern on both sides. Please see all photos for front and back detail and size reference with ruler.
*****If you need more than what I have available, contact me - if I don't have them on hand, I can get them usually within 5 business days*****
Height: 22.5mm
Width: 10.1mm
Hole ID: 1.6mm
Finish: Antique Pewter finish.
Quantities available during check-out:
2 charms
4 charms
***** Any photos of jewelry shown are for design ideas / or reference to size and detail. Jewelry is not included in the price of this listing*****
Tierra Cast is high quality plated (fine silver, gold, copper and rhodium) lead-free culinary-grade pewter. It is MADE IN AMERICA! The detail on their beads and findings are incredible. I absolutely love the quality. I love the fact that I am supporting an American company and keeping jobs here. Give it a try, you won't be disappointed!
Pretty much all of their items come in 4 finishes (silver, gold, copper and rhodium). I will slowly try to have all of the finishes. If you see something you like and would like it in a different finish, convo me and I'll get it ordered. Also, if you need a larger quantity, convo me – I probably have it on hand, or can order it rather quickly.
You can find out more about Tierra Cast on their website at www.tierracast.com. Also, if you see something you want that I don't have – convo me and I can get it ordered.
Thanks for looking.
PS: Please check out my Mom's Etsy site for some really beautiful Shabby Chic hand painted items and much more! She's at: artisticrenderings.etsy.com. Thanks!
1-3 business days
I'll do my best to meet these shipping estimates, but can't guarantee them. Actual delivery time will depend on the shipping method you choose.
Buyers are responsible for any customs and import taxes that may apply. I'm not responsible for delays due to customs.
Just contact me within: 14 days of delivery
Ship items back to me within: 21 days of delivery
But please contact me if you have any problems with your order.
Because of the nature of these items, unless they arrive damaged or defective, I can't accept returns for:
Buyers are responsible for return shipping costs. If the item is not returned in its original condition, the buyer is responsible for any loss in value.
I rely on a number of legal bases to collect, use, and share your information, including:
- Only as needed to provide my services, such as when I use your information to fulfill your order, to settle disputes, or to provide customer support
- Only if necessary to comply with a legal obligation or court order or in connection with a legal claim, such as retaining information about your purchases if required by tax law in my state and country; and
- Only as necessary for the purpose of my legitimate interests, if those legitimate interests are not overridden by your rights or interests, such as 1) providing and improving my services. I use your information to provide the services you requested and in my legitimate interest to improve my services; and 2) Compliance with the Etsy Seller Policy and Terms of Use. I use your information as necessary to comply with my obligations under the Etsy Seller Policy and Terms of Use.
Information about my customers is important to my business. I share your personal information for very limited reasons and in limited circumstances, as follows:
•Etsy. I share information with Etsy as necessary to provide you my services and comply with my obligations under both the Etsy Seller Policy and Etsy Terms of Use.
•Compliance with laws. I may collect, use, retain, and share your information if I have a good faith belief that it is reasonably necessary to: (a) respond to legal process or to government requests; (b) enforce my agreements, terms and policies; (c) prevent, investigate, and address fraud and other illegal activity, security, or technical issues; or (d) protect the rights, property, and safety of my customers, or others.
Retention of Data:
I retain your personal information only for as long as necessary to provide you with my services and as described in my Privacy Policy. However, I may also be required to retain this information to comply with my legal and regulatory obligations, to resolve disputes, and to enforce my agreements. I generally keep your data as available in my shop files.
Your rights as a buyer:
•Access. You may have the right to access and receive a copy of the personal information (which is name, address, email address and phone number) I keep about you by contacting me using the contact information below.
•Change, restrict, delete. You may also have rights to change, restrict my use of, or delete your personal information except for any information I need to fulfill legal obligations.
Additional information:
I have Google Analytics enabled in my shop. I have asked Google to retain the information for 26 months. I do not share the information received through Google unless required to for legal reasons.
I offer a 20% discount when you order larger quantities of the same item. Please contact me for information
For my handmade lampwork beads, I would love to work with you to make the color, size or quantity of your dreams :) Contact me for more information.
If the USPS behaves themselves First Class orders should arrive within 5 days. If you need it faster, you can choose Priority Shipping during checkout that should arrive within 2-3 days. International orders may take up to 4-6 weeks depending on your country's customs procedures.


text:
Below is our collection of tidbits, odds 'n ends for Audra.
This page contains three sections:
We spend a lot of time looking through Gazetteers that were published in the late 1800's and early 1900's. Many of the Gazetteers include the distance from a community such as Audra to various places of note, such as the White House.
With a nod to our favorite Gazetteers, the straight-line distance<1> beginning in Audra to:
While the name Audra is unique within West Virginia, we know of one more community in the United States.
Communities Outside of West Virginia
Taylor County
Our profile page for Audra, Taylor CountyThis community is historic.<7>Although located in Taylor County, we don't know the location of this community within the county.
As we travel, we always see a community with a name that gives pause. While there are names which are interesting or familiar, some catch our attention or strike our fancy. We always talk about such a name. If time permits and the community is not too far, we'll usually try to make a side-trip.
Cities, Towns and Villages of West Virginia
About Barbour County
About West Virginia
Unfortunately, we don't know of a website for Audra. If you can help, please contact us through our Feedback Page.
The official website for State of West Virginia: https://www.wv.gov/
- Return to Citation
Please keep in mind that we can not guarantee the accuracy or timeliness of the information
on this website, so use with care. We encourage you to double-check the information that is critical to you.
If you've found an error or have additional information that you would like to share,
please don't hesitate to write. Click here to contact us.


text:
|Episode Description
|Tuesday, Nov 27, 2012 - 4:00 PM
"Masked Bandits"
As they prepare for a creature costume party, the Wild Kratts team begins to notice all sorts of strange things happening in the Tortuga HQ. Jimmy is sure there is a ghost or monster living with them, but the Kratt brothers are convinced it's some kind of creature. When the gang sets out to discover who is causing all the trouble, they discover that certain animals gravitate towards human habitation because it provides food and protection from predators. D
Mountain Time
|More on IDAHO (MT)
|No upcoming shows in database
|Previous on IDAHO (MT)
|No Past shows in database


text:
Difference between revisions of "Payne Lab:News"
|Line 25:
|Line 25:

 --Candace will present her research at the [http://www.sga.gatech.edu/graduate/GTRIC Georgia Tech Research and Innovation Conference] on Feb. 12, 2-3:30pm in the GT Student Center Ballroom, poster board #149.

 --Candace will present her research at the [http://www.sga.gatech.edu/graduate/GTRIC Georgia Tech Research and Innovation Conference] on Feb. 12, 2-3:30pm in the GT Student Center Ballroom, poster board #149.

--Deb, Candace and Saheli will be traveling
--Deb, Candace and Saheli will be traveling to Philadelphia for the 57th annual meeting of the Biophysical Society Meeting from February 2nd - 6th.

Saheli will present her poster '''"Downregulation of NRF2 in HeLa Cells by Self-Conditioned Media"''', #B39, on Feb 4th at 1:45 pm in Hall C.

Saheli will present her poster '''"Downregulation of NRF2 in HeLa Cells by Self-Conditioned Media"''', #B39, on Feb 4th at 1:45 pm in Hall C.

Revision as of 07:03, 12 March 2013
--Nicole Thompson, our Faculty Support Coordinator, is getting a big promotion to work with the School of Physics! We had a surprise lunch for her and wished her the best of luck at her new position. Thanks for everything you've done for us Nicole- we're going to miss you!
--Candace will present her research at the Georgia Tech Research and Innovation Conference on Feb. 12, 2-3:30pm in the GT Student Center Ballroom, poster board #149.
--Deb, Candace and Saheli will be traveling to Philadelphia for the 57th annual meeting of the Biophysical Society Meeting from February 2nd - 6th.
Saheli will present her poster "Downregulation of NRF2 in HeLa Cells by Self-Conditioned Media", #B39, on Feb 4th at 1:45 pm in Hall C.
Deb will present his poster "Lysosome Mobility Probed With Live Cell Imaging and Single Particle Tracking", #B501, on Feb 6th in Hall C.
Candace will present her poster "Nanoparticle Surface Charge Directs the Cellular Binding of Nanoparticle-Protein Complexes": #S125, on Feb 3rd in the Exhibit Hall; and #B709 on Feb 5th in Hall C.
--We took Molly out to lunch on her last day in the lab and wished her well as she starts her first semester in the Nursing program at Georgia State University. Goodbye, Molly!
--We celebrated Joesph's graduation and wished him well as he begins his first "real" job at Medical Neurogenetics. Goodbye, Joseph!
--Candace was awarded the Women in Chemistry travel award for the Biophysical Society's Annual Meeting in Philadelphia next February. Congratulations!
--To celebrate National Chemistry Week, Christine was interviewed by Meg A. Mole (no relation to Whac A. Mole) for the ACS kids newsletter.
--Christine was part of a multidisciplinary panel on science, ethics, and medicine. The panel, HeLa @ Tech: Faculty Panel on Science, Ethics, and Medicine, explored a variety of topics related to the ethical responsibilities of researchers.
--Congratulations to Candace who was named a Molecular Biophysics senior trainee for 2012-2013!
--The Payne Lab competed in the Brown-Curtis-Payne Potluck Olympics. Deb and Deepali took the gold in the 'Best Substitution' and 'Best Overall' categories!
--Learn about Georgia Tech's BioEngineering Graduate Program!
--We celebrated Jairo's graduation and wished him well as he leaves the lab and moves to Austin. Goodbye, Jairo!
--Quachel gave her final NNIN talk at Georgia Tech. Her official talk will be webcast from Washington D.C. Her talk is Tuesday Minnesota Session 1 (8:35 AM).
--Welcome to Molly Flanagan, our new Lab Technician!
--Midtown Book Club visits the lab as part of their discussion of "The Immortal Life of Henrietta Lacks." To see more, check out our outreach page!
--Welcome to Ryan Lannan and Quachel Bazile, our new REU students!
--Rachel Candace Law will be doing summer research in the Payne and Potter (Biomedical Engineering) labs as a LINCR Fellow. Congratulations to Candace on her acceptance into the LINCR program!
--Candace and Jairo will be presenting posters at the Biophysical Society Annual Meeting in San Diego, Feb. 25-29.
Candace's poster: "Cellular Binding and Transport of Protein-Nanoparticle Complexes"; Sunday, Feb. 26; Poster # B775, Hall FGH
Jairo's poster: "Intracellular Dynamics of Lysosomes following the destruction of LAMP"; Sunday, Feb. 26; Poster #B843, Hall FGH
--Candace has advanced to candidacy!
--Steve will be part of a discussion panel on Nanomedicine on February 28th at the Georgia Institute of Technology Library.
Link to Video
--Two new undergrads have joined the Payne Lab. Welcome to Patrick and Kelsey!
--Jairo graduates!
--Umesh Kumar has joined the Payne Lab as a postdoc. Welcome Umesh!
--After successfully defending his thesis, Chip Humphries becomes Dr. Chip Humphries.
--Eddy Shin, a biochemistry graduate of the University of Georgia, joined the lab as our first Lab Technician. Welcome Eddy!
--Joseph Kim, a GT undergraduate biochemistry major joined the Payne Lab. Welcome Joseph!
--Christine's DARPA award and the Payne Lab are featured in a GT Sciences Video.
--Steve Hira has joined the Payne Lab as a postdoc. Welcome Steve!
--The Payne Lab's research on single particle tracking of vesicles is featured in the Emerging Investigator issue of the Analyst.
-- The Payne lab will be attending and presenting at the ACS National Meeting in Denver, Colorado from August 28th - September 1st.
- Christine will be presenting "Overview of the Advances in Microscopy Symposium for Undergrads" on Sunday (time TBD). She will also present "Imaging chemical reactions inside living cells: Two-color single particle tracking of the enzymatic degradation of low-density lipoprotein (LDL)" (Paper ID 10953) on Monday, August 29th in the session beginning at 8:20 am (Colorado Convention Center, Room 1B, Talk time: 11:40-12:10pm).
- Ger will be giving a talk on Tuesday, August 30th in the 8:20 am session (Convention Center, Room 4B, Talk time: 9:40-10:00 am); "Cellular binding and internalization of nanoparticles in the presence of serum proteins."
- Candace will be presenting her poster, "Imaging cellular internalization of nanoparticles with serum proteins using two-color fluorescence microscopy," on Monday, August 29th from 12-1 pm (Convention Center, Rooms 406/407) and on Wednesday, August 31st from 6-9 pm (Convention Center, Hall D, Poster #12038).
- Khalilah Reddie, our colaborator from the Murthy lab at Georgia Tech, will also be presenting her poster on Monday, August 29th from 12-1pm, "Aromatic Thiols: A New Family of Probes for Reversible Ratiometric Imaging of Thiols and Disulfides in Living Cells" (Convention Center, Rooms 406/407).
-Congratulations to Candace on her GAANN Fellowship for 2011-2012!
-Syeda presented her research at the REU poster session
-Christine received a DARPA Young Faculty Award.
-Congratulations to Hursh on his President's Undergraduate Research Award (PURA) for Fall 2011!
-Congratulations to Chip who now has a "real job" at B&B Microscopes in Pittsburgh!
-Joseph Bell, a physics major at Morehouse College, will be doing research in the Payne Lab this summer. Welcome Joseph!
-Syeda Anum, a biochemistry major from Northeastern University, has joined the Payne Lab as an NSF-REU student. Welcome Syeda!
-Saheli Sarkar joined the Payne and Kemp Labs!
-The Payne Lab will attend the Biophysical Society Annual Meeting in Baltimore, MD March 5-9, 2011. Following are details for our presentations.
Ger's poster, #1719, will be presented as part of the Imaging and Optical Microscopy II poster session March 7th at 1:45 in position B629. It is titled "Cellular Binding of Nanoparticles in the Presence of Serum Proteins".
Craig will present "Dynamic Behavior of Intracellular Vesicles Probed with Two-Color Single Particle Tracking" as part of the Intracellular Cargo Transport poster session on March 9th at 10:30. His poster, #3251, can be found at board B356.
Chip's poster, "Investigation of Lysosomes as Enzyme Storage Vesicles using Single Particle Tracking Fluorescence Microscopy", will be presented as part of the Imaging and Optical Microscopy III poster session on March 9th at 10:30. His poster, #3339, will be on board B444. He will also be presenting as part of the Student Research Achievement Award Poster Competition on Sunday night at 6pm, board #S164.
-Jairo passed his Naturalization Examination to become an American citizen!
Jairo downs his very American burger.
-Two new undergraduates, Jessica and Hursh, join the Payne Lab.
-Christine was featured as an "Emerging Investigator" in Chemical Communications.
-The annual Payne-Brown-Curtis Lab Christmas Party was a great success.
Candace opens a grab bag gift.
-Chip presented a poster at the Second Academia/Industry Forum at Kennesaw State University. This was sponsored by the Georgia Section of the American Chemical Society and Kennesaw State University.
-Congratulations to Candace on being named a Molecular Biophysics trainee!
-Candace joins the Payne Lab.
-Congrats to Jairo and Heather on winning PURA fellowships for Summer 2010!
-Dr. Gerard Doorley joins the Payne Lab.
-Update on Past Members:
Solaire will be attending the University of Minnesota to pursue a Ph.D. in Chemistry.
Nicole, now at UC Berkeley, received an NSF Graduate Fellowship. Congratulations!
Jenna has joined the O'Brien Lab at the University of Michigan.
-The Payne Lab hosted a number of visitors from local high schools. Please see our Outreach page for photos.
-Chip presented a poster at the Biophysical Society Annual Meeting in San Francisco. His poster was titled Late Endosomal Degradation of Low-Density Lipoprotein Probed with Multi-Color Single Particle Tracking Fluorescence Microscopy.
-Chip won a student travel grant from the Georgia Tech Research and Innovation Conference. Congrats to Chip!.
-Heather joined the Payne Lab.
-At the Georgia Tech Holiday Party, Chip won a Chemmy for the "Best Actor Portraying Chip"! The Payne Lab submitted this video as part of the holiday activities.
-Jairo received a President's Undergraduate Research Award for Spring 2010. Great job Jairo!
-Don won a Young Investigator Award for his poster presentation at the Society for Free Radical Biology and Medicine annual meeting in San Francisco!
-Chip was awarded a 2010 Student Travel Award from the Biophysical Society to attend the 54th Annual Meeting in San Francisco, CA.
-As part of National Chemistry Week, the Payne Lab was featured on Georgia Tech's radio station, WREK, as part of Inside the Black Box's program "Chemistry - It's Elemental".
-Chip earned third place in the School of Chemistry and Biochemistry's Graduate Research Symposium with his oral presentation, "Late Endosomal Degradation of Low-Density Lipoprotein Probed with Two-Color Fluorescence Microscopy".
-Congratulations to CKP for being named a recipient of the 2009 NIH Director's Young Innovator award.
-Jairo and Chip's proposal to the Georgia Tech Undergraduate Research Opportunities Program was funded! This will provide funding for Jairo's automation of Chip's image analysis.
-Craig joined the group as a post-doc after completing his Ph.D. with Prof. Jason McNeill at Clemson.
-Amy was named a Georgia Tech Molecular Biophysics Trainee for 2009-2010. This award includes a salary supplement and a chance to give a Molecular Biophysics seminar. Only two awards were made this year. Congrats Amy!
-The Brown, Curtis, and Payne labs hosted first-year students from Physics, Chemistry, and Computational Science & Engineering for an open house.
Open House Flyer
-Jairo, Josh and Paul joined the Payne Lab.
-Solaire participated in the REU poster session and research symposium before returning to Minnesota for her senior year of college. We wish her luck!
-The Payne Lab went to Chip's Wedding
-Solaire joined the Payne Lab as a summer REU student.
-Kevin and Mindi gradutate! Mindi has completed her Masters and is looking forward to becoming a high school teacher. Kevin earned his B.S. in Chemistry and is looking to continue his education in a MD/PhD program.
Kevin and Mindi enjoy the celebration.
-Kevin was awarded Best Oral Presentation in the College of Sciences at the 2009 Undergraduate Research Spring Symposium!
Kevin and Georgia Tech President Bud Peterson.
-Amy and Chip presented posters at the Biophysical Society Meeting in Boston, MA. Amy's poster was number B50 and is titled Non-Invasive Pyrenebutyrate-mediated Delivery of Quantum Dots to the Cytosol of Living Cells. Chip's poster was number B57 and is titled Probing the Intracellular Degradation of Low Density Lipoprotein Using Single Particle Tracking Fluorescence Microscopy.
-Amy's paper "Pyrenebutyrate-Mediated Delivery of Quantum Dots across the Plasma Membrane of Living Cells" was published in the 113th volume of The Journal of Physical Chemistry B.
-Ashlee was awarded a Center for Integrated Nanotechnologies award to work on "Delivery of nanomaterials across the blood-brain barrier: Three-dimensional tracking of transcytosis" at Los Alamos National Laboratory.
-Aaron and Emily joined the Payne Lab
-Kevin won a PURA fellowship!
-Kevin joined the Payne Lab
-Dr. Ashlee St John joined the Payne Lab as our first Post-Doc
-Mindi was named a Georgia Tech Molecular Biophysics Trainee for 2008-2009
-Jenna joined the lab as an REU student for the summer, Nicole heads off to the University of California at Berkeley for graduate school, the Payne lab went to dinner to welcome Jesse and Jenna and to say 'goodbye' to Nicole.
-Nicole graduated with a B.S in Biology and a B.S. in Biochemistry with highest honors.
-Amy was awarded a Center for Drug Design, Development and Delivery GAANN fellowship for the 2008-2009 academic year.
-Nicole was awarded the Williams-Walls Award. This is an award given to a graduating woman in the life sciences at Georgia Tech with an outstanding academic record and who has plans to continue her education at the graduate level.
-Payne Lab research was highlight in Drug Discovery and Design Magazine[1]
-Nicole was named the College of Sciences Top Undergraduate Researcher!
-Jesse won a PURA fellowship!
-Christine traveled to Tunisia for the 1st North Africa-USA Regional Workshop on Nanostructured Materials and Nanotechnology.[2]
-Jesse joined the Payne Lab
-Christine traveled to the 52nd Annual Biophysical Society Meeting in Long Beach, California.[3]
-Christine was awarded an ACS PROGRESS/Dreyfus Lectureship.
-Mindi and Amy joined the Payne Lab
-Christine won a NIH Research Scholar Development Award.
-Chip was named a Georgia Tech Molecular Biophysics Trainee for 2007-2008.
-Nicole won PURA and Merck fellowships.
-Payne Lab complete.


text:
Celebration Cakes
- - Per Seat
What You Will Learn
With this class created by the editors of Better Homes and Gardens exclusively for Sur La Table, you'll learn how to bake and decorate impressive and scrumptious cakes! The penultimate treat is all about comfort, pleasure and soul, and it combines sweet aromas from the oven with the soft texture of delicate crumb as you enjoy a perfect bite. Discover a treasure trove of inspiration and hands-on step-by-step instruction on baking, constructing and decorating stylish and sophisticated cakes for summer celebrating, showers, birthday parties, afternoon teas and more.
*Class bonus: Included with your purchase of this class is a 12-month subscription to Better Homes and Gardens (a $6.00 value). Subscription and rebate information will be distributed at the class.
What To Expect:
Great cooking isn't about recipes—it's about techniques. In our classes you'll work together with other students in a fun, hands-on environment led by our professional chef instructors.
- Learn fundamental skills for a lifetime of great cooking
- Work side-by-side with other students to prepare each dish
- Interact with classmates and the instructor for a rich learning experience
- Classes are 2 to 2 1/2 hours and each student enjoys a generous taste of every dish
- Held in our professional teaching kitchens, each class is led by experienced chef instructors
- Students receive a 10% discount coupon to use the week after the class
Danielle Disanto


text:
Henderson County's land-use rules are critical to keeping it livable and prosperous, an environmental group told a regulation review advisory committee Thursday, and should be enhanced, not dismantled.
Henderson County's land-use rules are critical to keeping it livable and prosperous, an environmental group told a regulation review advisory committee Thursday, and should be enhanced, not dismantled.
Rachel Hodge, executive director of the Environmental and Conservation Organization, urged the committee to recommend that commissioners strengthen the county's land development code by incorporating more aspects of a comprehensive plan revised in 2008.
"Some people really are just not fans of zoning and aren't fans of ordinance codes and I totally understand that," said Hodge. "ECO understands that; we get that. But the point is, we can work together to find ways to keep the strong codes we already have and enhance them..."
Hodge urged the committee to recommend that commissioners create an open-space plan to protect farms and forests and to keep development compatible with the "rural and scenic character of the county," two areas that received strong public support during the plan revision process.
Existing regulations such as stormwater rules and erosion controls "help keep our property values up," Hodges said, and retain the high quality of life in Henderson County that draws industries such as Sierra Nevada and Legacy Paddlesports to create jobs here.
Large commercial and industrial developments should be kept within the plan's Urban Services Area — the boundary served by water and sewer lines — and away from floodplains, wetlands and steep slopes, Hodge advised.
ECO was the final group invited to make a presentation before the committee, which commissioners created to examine how they can make county code more business friendly. The committee has also heard from the Chamber of Commerce, economic development officials and area homebuilders.
In six meetings since April, committee members haven't heard much negative feedback about specific codes burdensome to businesses, other than a sign ordinance issue, but they have identified some regulatory "bottlenecks" that could potentially slow economic growth.
"Going back to the presentations, we've heard a lot of good things and it's really good to hear from different angles about good things that Henderson County has done," said Chairman Bert Lemkes. "But what we've also heard is sometimes — not always, but sometimes — the process gets lengthy for no specific reason."
Last month, Lemkes asked county staff to develop a flow chart showing the timeline for rezonings and other county reviews that affect businesses trying to open up a new store or facility, in hopes of streamlining the process.
Based on that flow chart, the committee Thursday explored the possibility of speeding up the rezoning approval process. They considered that on the same day a business applies for a rezoning, a date be set by county staff for commissioners to hold a required public hearing.
That could shorten the process, said County Attorney Russ Burrell, but commissioners would have to approve allowing staff to set a public hearing that early. He added that businesses would also have to accept the risk that a delayed decision by the county's planning board — which recommends rezonings to the commissioners — could throw off the accelerated timetable.
Committee member Renee Kumor wondered if condensing the process would create a situation where an adjacent landowner who was out of town wouldn't find out about the rezoning's public hearing until after it was over. No, said member Larry Baber, the shortened process would still give adequate public notice while speeding things up.
Planning board member Mike Cooper, who sits on the committee as a non-voting member, offered another suggestion for commissioners: lowering the county's permit fees. He said fees for a $3 million commercial project like the Boyd Automotive facility he's building on Spartanburg Highway are $21,350 here, compared to $7,825 in Burke County, $11,402 in Jackson or $10,010 in Polk for the same project.
"We have one of the highest (commercial) rate schedules for building permits in the western part of the state," Cooper said.
Reach Axtell at 828-694-7860 or firstname.lastname@example.com.